| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |